SGH
GILD icon

Sivik Global Healthcare’s Gilead Sciences GILD Stock Holding History

Sivik Global Healthcare’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Hold
25,000
– – 2.65% 16
2026
Q1 		$3.48M Hold
25,000
– – 2.65% 16
2025
Q4 		$3.07M Buy
+25,000
New +$3.04M 0.89% 41
2025
Q3 		– Sell
-50,000
Closed -$5.54M – 51
2025
Q2 		$5.54M Buy
50,000
+10,000
+25% +$1.06M 1.51% 25
2025
Q1 		$4.48M Buy
+40,000
New +$4.13M 2.42% 22
2020
Q3 		– Sell
-50,000
Closed -$3.85M – 50
2020
Q2 		$3.85M Buy
+50,000
New +$3.83M 1.27% 36
2017
Q4 		– Sell
-80,000
Closed -$6.48M – 75
2017
Q3 		$6.48M Sell
80,000
-10,000
-11% -$765K 2.21% 21
2017
Q2 		$6.37M Buy
+90,000
New +$5.99M 2.33% 14
2017
Q1 		– Sell
-80,000
Closed -$5.73M – 61
2016
Q4 		$5.73M Buy
+80,000
New +$5.95M 2.73% 14
2016
Q3 		– Sell
-36,617
Closed -$3.05M – 53
2016
Q2 		$3.05M Sell
36,617
-28,383
-44% -$2.52M 1.52% 36
2016
Q1 		$5.97M Buy
+65,000
New +$5.86M 2.64% 10
2015
Q4 		– Sell
-55,000
Closed -$5.4M – 63
2015
Q3 		$5.4M Buy
55,000
+15,500
+39% +$1.72M 2.62% 12
2015
Q2 		$4.63M Sell
39,500
-50,500
-56% -$5.52M 1.6% 23
2015
Q1 		$8.83M Buy
90,000
+50,300
+127% +$5.11M 3.01% 2
2014
Q4 		$3.74M Buy
+39,700
New +$4.11M 1.52% 27
2014
Q2 		– Sell
-25,000
Closed -$1.77M – 75
2014
Q1 		$1.77M Sell
25,000
-20,000
-44% -$1.57M 1.11% 47
2013
Q4 		$3.38M Buy
+45,000
New +$3.13M 2.4% 11

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Sivik Global Healthcare's GILD Position: Q2 2026 in Review

Sivik Global Healthcare held its Gilead Sciences (GILD) position steady in Q2 2026 at 25,000 shares worth $3.48M. The position accounts for 2.65% of the portfolio, ranked #16.

Sivik Global Healthcare first reported a position in GILD in Q4 2013 and has held it in 17 quarters since. The position peaked at $8.83M in Q1 2015. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sivik Global Healthcare held 25,000 shares of Gilead Sciences worth $3.48M as of Q2 2026.
  • Sivik Global Healthcare left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 2.65% of Sivik Global Healthcare's portfolio in Q2 2026, its #16 holding.
  • Sivik Global Healthcare first reported a position in Gilead Sciences in Q4 2013 and has held it in 17 quarters since.
  • Sivik Global Healthcare's Gilead Sciences position peaked at $8.83M in Q1 2015.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.